Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 34

1.

Alcohol intake, tobacco smoking, and esophageal adenocarcinoma survival: a molecular pathology epidemiology cohort study.

McCain RS, McManus DT, McQuaid S, James JA, Salto-Tellez M, Reid NB, Craig S, Chisambo C, Bingham V, McCarron E, Parkes E, Turkington RC, Coleman HG.

Cancer Causes Control. 2020 Jan;31(1):1-11. doi: 10.1007/s10552-019-01247-2. Epub 2019 Nov 30.

2.

Comparison of Molecular Assays for HPV Testing in Oropharyngeal Squamous Cell Carcinomas: A Population-Based Study in Northern Ireland.

Craig SG, Anderson LA, Moran M, Graham L, Currie K, Rooney K, Robinson M, Bingham V, Cuschieri KS, McQuaid S, Schache AG, Jones TM, McCance D, Salto-Tellez M, McDade SS, James JA.

Cancer Epidemiol Biomarkers Prev. 2020 Jan;29(1):31-38. doi: 10.1158/1055-9965.EPI-19-0538. Epub 2019 Oct 30.

PMID:
31666283
3.

Fibroblast-derived Gremlin1 localises to epithelial cells at the base of the intestinal crypt.

Dutton LR, Hoare OP, McCorry AMB, Redmond KL, Adam NE, Canamara S, Bingham V, Mullan PB, Lawler M, Dunne PD, Brazil DP.

Oncotarget. 2019 Jul 23;10(45):4630-4639. doi: 10.18632/oncotarget.27050. eCollection 2019 Jul 23.

4.

A Novel Role for Cathepsin S as a Potential Biomarker in Triple Negative Breast Cancer.

Wilkinson RDA, Burden RE, McDowell SH, McArt DG, McQuaid S, Bingham V, Williams R, Cox ÓT, O'Connor R, McCabe N, Kennedy RD, Buckley NE, Scott CJ.

J Oncol. 2019 Jun 27;2019:3980273. doi: 10.1155/2019/3980273. eCollection 2019.

5.

NUP98 - a novel predictor of response to anthracycline-based chemotherapy in triple negative breast cancer.

Mullan PB, Bingham V, Haddock P, Irwin GW, Kay E, McQuaid S, Buckley NE.

BMC Cancer. 2019 Apr 2;19(1):236. doi: 10.1186/s12885-019-5407-9.

6.

Recommendations for determining HPV status in patients with oropharyngeal cancers under TNM8 guidelines: a two-tier approach.

Craig SG, Anderson LA, Schache AG, Moran M, Graham L, Currie K, Rooney K, Robinson M, Upile NS, Brooker R, Mesri M, Bingham V, McQuaid S, Jones T, McCance DJ, Salto-Tellez M, McDade SS, James JA.

Br J Cancer. 2019 Apr;120(8):827-833. doi: 10.1038/s41416-019-0414-9. Epub 2019 Mar 20.

7.

Automated Tumour Recognition and Digital Pathology Scoring Unravels New Role for PD-L1 in Predicting Good Outcome in ER-/HER2+ Breast Cancer.

Humphries MP, Hynes S, Bingham V, Cougot D, James J, Patel-Socha F, Parkes EE, Blayney JK, O'Rorke MA, Irwin GW, McArt DG, Kennedy RD, Mullan PB, McQuaid S, Salto-Tellez M, Buckley NE.

J Oncol. 2018 Dec 17;2018:2937012. doi: 10.1155/2018/2937012. eCollection 2018.

8.

Sex hormone receptor expression and survival in esophageal adenocarcinoma: a prospective cohort study.

McMenamin ÚC, Trainor J, Coleman HG, McManus DT, McQuaid S, Bingham V, James J, Salto-Tellez M, Johnston BT, Turkington RC.

Oncotarget. 2018 Oct 19;9(82):35300-35312. doi: 10.18632/oncotarget.26236. eCollection 2018 Oct 19.

9.

High PTGS2 expression in post-neoadjuvant chemotherapy-treated oesophageal adenocarcinoma is associated with improved survival: a population-based cohort study.

Spence AD, Trainor J, McMenamin Ú, Turkington RC, McQuaid S, Bingham V, James J, Salto-Tellez M, McManus DT, Johnston BT, Cardwell CR, Coleman HG.

Histopathology. 2019 Mar;74(4):587-596. doi: 10.1111/his.13786. Epub 2019 Jan 25.

PMID:
30408225
10.

Vitamin D receptor as a marker of prognosis in oesophageal adenocarcinoma: a prospective cohort study.

McCain S, Trainor J, McManus DT, McMenamin ÚC, McQuaid S, Bingham V, James JA, Salto-Tellez M, Turkington RC, Coleman HG.

Oncotarget. 2018 Sep 28;9(76):34347-34356. doi: 10.18632/oncotarget.26151. eCollection 2018 Sep 28.

11.

Critical Appraisal of Programmed Death Ligand 1 Reflex Diagnostic Testing: Current Standards and Future Opportunities.

Humphries MP, McQuaid S, Craig SG, Bingham V, Maxwell P, Maurya M, McLean F, Sampson J, Higgins P, Greene C, James J, Salto-Tellez M.

J Thorac Oncol. 2019 Jan;14(1):45-53. doi: 10.1016/j.jtho.2018.09.025. Epub 2018 Oct 6.

12.

Bcl-xL as a poor prognostic biomarker and predictor of response to adjuvant chemotherapy specifically in BRAF-mutant stage II and III colon cancer.

Dunne PD, Coleman HG, Bankhead P, Alderdice M, Gray RT, McQuaid S, Bingham V, Loughrey MB, James JA, McCorry AMB, Gilmore A, Holohan C, Klingbiel D, Tejpar S, Johnston PG, McArt DG, Di Nicolantonio F, Longley DB, Lawler M.

Oncotarget. 2018 Feb 13;9(17):13834-13847. doi: 10.18632/oncotarget.24481. eCollection 2018 Mar 2.

13.

RNAscope in situ hybridization confirms mRNA integrity in formalin-fixed, paraffin-embedded cancer tissue samples.

Bingham V, McIlreavey L, Greene C, O'Doherty E, Clarke R, Craig S, Salto-Tellez M, McQuaid S, Lewis C, James J.

Oncotarget. 2017 Oct 16;8(55):93392-93403. doi: 10.18632/oncotarget.21851. eCollection 2017 Nov 7.

14.

Natural killer-like signature observed post therapy in locally advanced rectal cancer is a determinant of pathological response and improved survival.

Alderdice M, Dunne PD, Cole AJ, O'Reilly PG, McArt DG, Bingham V, Fuchs MA, McQuaid S, Loughrey MB, Murray GI, Samuel LM, Lawler M, Wilson RH, Salto-Tellez M, Coyle VM.

Mod Pathol. 2017 Sep;30(9):1287-1298. doi: 10.1038/modpathol.2017.47. Epub 2017 Jun 16.

15.

Molecular profiling of signet ring cell colorectal cancer provides a strong rationale for genomic targeted and immune checkpoint inhibitor therapies.

Alvi MA, Loughrey MB, Dunne P, McQuaid S, Turkington R, Fuchs MA, McGready C, Bingham V, Pang B, Moore W, Maxwell P, Lawler M, James JA, Murray GI, Wilson RH, Salto-Tellez M.

Br J Cancer. 2017 Jul 11;117(2):203-209. doi: 10.1038/bjc.2017.168. Epub 2017 Jun 8.

16.

Statin use, candidate mevalonate pathway biomarkers, and colon cancer survival in a population-based cohort study.

Gray RT, Loughrey MB, Bankhead P, Cardwell CR, McQuaid S, O'Neill RF, Arthur K, Bingham V, McGready C, Gavin AT, James JA, Hamilton PW, Salto-Tellez M, Murray LJ, Coleman HG.

Br J Cancer. 2017 Jun 6;116(12):1652-1659. doi: 10.1038/bjc.2017.139. Epub 2017 May 18.

17.

Evaluation of PTGS2 Expression, PIK3CA Mutation, Aspirin Use and Colon Cancer Survival in a Population-Based Cohort Study.

Gray RT, Cantwell MM, Coleman HG, Loughrey MB, Bankhead P, McQuaid S, O'Neill RF, Arthur K, Bingham V, McGready C, Gavin AT, Cardwell CR, Johnston BT, James JA, Hamilton PW, Salto-Tellez M, Murray LJ.

Clin Transl Gastroenterol. 2017 Apr 27;8(4):e91. doi: 10.1038/ctg.2017.18.

18.

Gremlin1 plays a key role in kidney development and renal fibrosis.

Church RH, Ali I, Tate M, Lavin D, Krishnakumar A, Kok HM, Hombrebueno JR, Dunne PD, Bingham V, Goldschmeding R, Martin F, Brazil DP.

Am J Physiol Renal Physiol. 2017 Jun 1;312(6):F1141-F1157. doi: 10.1152/ajprenal.00344.2016. Epub 2017 Jan 18.

19.

Transcriptional upregulation of c-MET is associated with invasion and tumor budding in colorectal cancer.

Bradley CA, Dunne PD, Bingham V, McQuaid S, Khawaja H, Craig S, James J, Moore WL, McArt DG, Lawler M, Dasgupta S, Johnston PG, Van Schaeybroeck S.

Oncotarget. 2016 Nov 29;7(48):78932-78945. doi: 10.18632/oncotarget.12933.

20.

PTEN mRNA detection by chromogenic, RNA in situ technologies: a reliable alternative to PTEN immunohistochemistry.

Bingham V, Ong CW, James J, Maxwell P, Waugh D, Salto-Tellez M, McQuaid S.

Hum Pathol. 2016 Jan;47(1):95-103. doi: 10.1016/j.humpath.2015.09.009. Epub 2015 Sep 25.

PMID:
26518664
21.

Comprehensive molecular pathology analysis of small bowel adenocarcinoma reveals novel targets with potential for clinical utility.

Alvi MA, McArt DG, Kelly P, Fuchs MA, Alderdice M, McCabe CM, Bingham V, McGready C, Tripathi S, Emmert-Streib F, Loughrey MB, McQuaid S, Maxwell P, Hamilton PW, Turkington R, James JA, Wilson RH, Salto-Tellez M.

Oncotarget. 2015 Aug 28;6(25):20863-74.

22.

Rescue of glandular dysmorphogenesis in PTEN-deficient colorectal cancer epithelium by PPARγ-targeted therapy.

Jagan I, Fatehullah A, Deevi RK, Bingham V, Campbell FC.

Oncogene. 2013 Mar 7;32(10):1305-15. doi: 10.1038/onc.2012.140. Epub 2012 Apr 30.

23.

PTEN regulates colorectal epithelial apoptosis through Cdc42 signalling.

Deevi R, Fatehullah A, Jagan I, Nagaraju M, Bingham V, Campbell FC.

Br J Cancer. 2011 Oct 25;105(9):1313-21. doi: 10.1038/bjc.2011.384. Epub 2011 Sep 27.

24.

Enhanced lymphocyte interferon (IFN)-γ responses in a PTEN mutation-negative Cowden disease kindred.

Stevenson R, Fatehullah A, Jagan I, Deevi RK, Bingham V, Irvine AE, Armstrong M, Morrison PJ, Dimmick I, Stewart R, Campbell FC.

Clin Exp Immunol. 2011 May;164(2):202-10. doi: 10.1111/j.1365-2249.2011.04336.x. Epub 2011 Mar 1.

25.

The yin and yang of vitamin D receptor (VDR) signaling in neoplastic progression: operational networks and tissue-specific growth control.

Campbell FC, Xu H, El-Tanani M, Crowe P, Bingham V.

Biochem Pharmacol. 2010 Jan 1;79(1):1-9. doi: 10.1016/j.bcp.2009.09.005. Epub 2009 Sep 6. Review.

26.

Vitamin D receptor modulates the neoplastic phenotype through antagonistic growth regulatory signals.

Xu H, McCann M, Zhang Z, Posner GH, Bingham V, El-Tanani M, Campbell FC.

Mol Carcinog. 2009 Aug;48(8):758-72. doi: 10.1002/mc.20520.

PMID:
19184984
27.

Expression of Nav1.9 channels in human dental pulp and trigeminal ganglion.

Wells JE, Bingham V, Rowland KC, Hatton J.

J Endod. 2007 Oct;33(10):1172-6. Epub 2007 Aug 27.

PMID:
17889684
28.

Translation of the synaptonemal complex component Sycp3 is enhanced in vivo by the germ cell specific regulator Dazl.

Reynolds N, Collier B, Bingham V, Gray NK, Cooke HJ.

RNA. 2007 Jul;13(7):974-81. Epub 2007 May 25.

29.

The influence of spirituality on family management of Parkinson's disease.

Bingham V, Habermann B.

J Neurosci Nurs. 2006 Dec;38(6):422-7.

PMID:
17233512
30.

Sex-specific regulation of growth plate chondrocytes by estrogen is via multiple MAP kinase signaling pathways.

McMillan J, Fatehi-Sedeh S, Sylvia VL, Bingham V, Zhong M, Boyan BD, Schwartz Z.

Biochim Biophys Acta. 2006 Apr;1763(4):381-92. Epub 2006 Mar 23.

31.

Dazl binds in vivo to specific transcripts and can regulate the pre-meiotic translation of Mvh in germ cells.

Reynolds N, Collier B, Maratou K, Bingham V, Speed RM, Taggart M, Semple CA, Gray NK, Cooke HJ.

Hum Mol Genet. 2005 Dec 15;14(24):3899-909. Epub 2005 Nov 8.

PMID:
16278232
32.

Characterization of a QTL affecting skeletal size in mice.

Christians JK, Bingham VK, Oliver FK, Heath TT, Keightley PD.

Mamm Genome. 2003 Mar;14(3):175-83.

PMID:
12647240
33.
34.

Postmortem biochemical markers of experimentally induced hypomagnesaemic tetany in sheep.

McCoy MA, Bingham V, Hudson AJ, Cantley L, Hutchinson T, Davison G, Fitzpatrick DA, Kennedy DG.

Vet Rec. 2001 Feb 24;148(8):233-7.

PMID:
11289550

Supplemental Content

Loading ...
Support Center